Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2007

Bavarian Nordic and GSK Terminate Partnership on Smallpox Vaccine

  • Bavarian Nordic agreed with GlaxoSmithKline not to pursue a collaboration for the production and marketing of Imvamune®, a third-generation smallpox vaccine under development.

    The companies had previously signed a memorandum to ensure sufficient production capacity from several facilities and distribution of imvamune to various international markets at a time where Bavarian Nordic’s production facility was not established. Now Bavarian Nordic says it has the capacity to produce the expected RFP-III order.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »